Target intelligence / Profile preview

Gram-negative bacterial cell membrane

Molecular classification
Other (not a single molecule or protein, but a complex biological structure), Membrane structure, Bacterial cell envelope component
01

Overview

The **Gram-negative bacterial cell membrane**—more accurately termed the *outer membrane*—is a defining structural feature found exclusively in Gram-negative bacteria. It forms part of a multilayered envelope that also includes an inner cytoplasmic (plasma) membrane and a thin peptidoglycan layer sandwiched between them. The **outer leaflet** is rich in **lipopolysaccharide** (LPS), which acts both as an essential barrier against toxic compounds—including many antibiotics—and as an important virulence factor responsible for strong immune reactions when released into host tissues ("endotoxin"). The inner leaflet consists mainly of phospholipids. Embedded within this asymmetric bilayer are various proteins such as **porins**, which facilitate selective uptake of nutrients while restricting entry by harmful substances. Structural proteins like Braun’s lipoprotein anchor the peptidoglycan layer to the outer membrane, providing additional stability.[1][2][3][6] This complex architecture gives rise not only to unique staining properties under laboratory conditions but also underpins much of what makes these organisms challenging clinical pathogens—including their ability both to resist antibiotic penetration and provoke robust host immune responses.[1][2] Note on correctness/target status: The "Gram-negative bacterial cell membrane" is not considered a canonical therapeutic target like receptors or enzymes; it is instead an anatomical/structural feature composed itself out of multiple molecular components. If you seek information about druggable targets within this system—for example, "lipopolysaccharide," "porin," or specific transporters—those would be more appropriate entries for structured data extraction.[6]

Other names
Gram-negative outer membraneGram-negative cell envelope (sometimes used interchangeably, but technically refers to all layers)LPS-diderm (scientific term for bacteria with a lipopolysaccharide-containing outer membrane)[6]
02

Mechanism of action

For drugs like polymyxins: * Bind to LPS and phospholipids in the outer membrane, disrupting its integrity leading to increased permeability and cell death. For other antibiotics: * Must traverse the outer membrane via porin channels before reaching intracellular targets; resistance can arise from altered porin expression.

03

Biological functions

Acts as a selective permeability barrier[2][3][4]Protects against environmental stress and antibiotics[1][3]Contributes to bacterial shape and mechanical strength[1]Contains virulence factors such as lipopolysaccharide (LPS)[2][4]Facilitates nutrient uptake via porins and transporters[3][4]
04

Disease associations

Infection (major determinant of pathogenicity in many bacteria due to LPS/endotoxin content)[2][4]Immune response activation through endotoxin release and PAMP recognition[4]
05

Safety considerations

Intrinsic resistance of Gram-negative bacteria due to low permeability of the outer membrane for many antibiotics[1][3].Release of endotoxins upon lysis can cause severe inflammatory responses/sepsis during treatment ("endotoxin shock")[2][4].
06

Interacting drugs

Polymyxins (e.g., colistin)

1 more in the full profile.

07

Biomarkers

No standard biomarkers for patient selection specific to this target; however, detection of LPS/endotoxin in blood can be used as an indicator of Gram-negative infection severity.

Beyond the preview

Go deeper on Gram-negative bacterial cell membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gram-negative bacterial cell membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call